Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Intangibles: 2010-2024

Historic Intangibles for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $2.5 million.

  • Anika Therapeutics' Intangibles fell 68.49% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 68.49%. This contributed to the annual value of $2.5 million for FY2024, which is 87.45% down from last year.
  • According to the latest figures from FY2024, Anika Therapeutics' Intangibles is $2.5 million, which was down 87.45% from $19.8 million recorded in FY2023.
  • Anika Therapeutics' Intangibles' 5-year high stood at $118.9 million during FY2020, with a 5-year trough of $2.5 million in FY2024.
  • In the last 3 years, Anika Therapeutics' Intangibles had a median value of $19.8 million in 2023 and averaged $44.8 million.
  • Per our database at Business Quant, Anika Therapeutics' Intangibles soared by 321.40% in 2020 and then tumbled by 87.45% in 2024.
  • Over the past 5 years, Anika Therapeutics' Intangibles (Yearly) stood at $118.9 million in 2020, then dropped by 5.15% to $112.7 million in 2021, then decreased by 0.53% to $112.1 million in 2022, then plummeted by 82.31% to $19.8 million in 2023, then crashed by 87.45% to $2.5 million in 2024.